Traditional biomarkers such as carcinoembryonic antigen (CEA) and cancer antigen 19–9 (CA19-9) have improved the diagnostic accuracy of PaCa, but they are less specific for PaCa [75]. This evidence concerns the gene CEACAM5 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.